Budget Highlights 2023
India's domestic pharmaceutical market is estimated at $41 billion in 2021 and is likely to grow to
Dr. Reddy’s successfully completes clinical studies of its rituximab biosimilar for filing in the
Chat GPT3 predicts the year in biotech says Cytiva
USFDA issues a CRL for the Biologics License Application for Insulin-R
- Posted On: 01-02-2023 Key Budget Highlights
- Posted On: 31-01-2023 Domestic pharmaceutical market to reach $130 bn by 2030
- Posted On: 20-01-2023 Dr. Reddy’s successfully completes clinical studies of its rituximab biosimilar for filing in the U.S., Europe
- Posted On: 09-01-2023 Chat GPT3 predicts the year in biotech says Cytiva
- Posted On: 07-01-2023 USFDA issues a CRL for the Biologics License Application for Insulin-R
About ABLE
Association of Biotechnology Led Enterprises - ABLE is a not-for-profit pan-India forum that represents the Indian Biotechnology Sector. It was launched in April 2003, after industry leaders felt a need to form an exclusive forum to represent the Indian Biotechnology Sector.
ABLE has over 400 members from all across India representing all verticals of the sector like Agribiotech, Bio-pharma, Industrial biotech, Bioinformatics, Investment banks and Venture Capital Firms and Equipment Suppliers.
The primary focus of ABLE is to accelerate the pace of growth of the Biotechnology sector in India, through partnering with the Government in their biotechnology initiatives to deliver optimal policies and create a positive...
Book your Booth Space!
ABLE 20th Anniversary Celebration in Delhi
Conference / Events
BIO Boston 2023
View more
Seminar on "Karnataka Biotechnology Industry & Entrepreneurship Development"
View moreMonthly Newsletter
Government nod for biotech R&D promotion scheme
Incentivize Research to make India a $500 billion BioEconomy by 2030